NCT04395469View on ClinicalTrials.gov

FAZA PET/MRI Pancreas

NAActive, not recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

May 18, 2021

Primary Completion Date

March 31, 2025

Study Completion Date

March 31, 2025

Conditions
Pancreatic Adenocarcinoma Non-resectableLocally Advanced Pancreatic AdenocarcinomaUnresectable Pancreatic Cancer
Interventions
DRUG

18F-FAZA

18F-FAZA is a radiotracer used for PET imaging (in combination with MRI) to detect hypoxia in tumours. This scan will be done before and after radiation treatment.

Trial Locations (1)

M5G 2C1

Princess Margaret Cancer Centre, Toronto

All Listed Sponsors
lead

University Health Network, Toronto

OTHER